Constellation Brands Inc. Common Stock vs Zimmer Biomet Holdings Inc — how do they compare? Constellation Brands Inc. Common Stock trades at $128.03 (market cap $21.50B), while Zimmer Biomet Holdings Inc trades at $92.24 (market cap $17.56B). The key difference: Constellation Brands Inc. Common Stock is the larger of the two by market cap, and Constellation Brands Inc. Common Stock pays the higher dividend (3.24%). Which is the better fit depends on your goals.
| STZ | ZBH | |
|---|---|---|
Market Cap | $21.50B | $17.56B |
Volume | 2,104,680 | 2,298,426 |
Sector | Consumer Staples | Health |
52-Week High | $166.68 | $103.98 |
52-Week Low | $112.77 | $79.58 |
Enterprise Value | $31.72B | $24.63B |
Dividend Yield | 3.24% | 1.04% |
Typical Hold Time | — | 89 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zimmer Biomet (ZBH) trades at $91.77, down 0.43% on the day, with a bullish technical signal supported by moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady at $8.23B for 2025, though net income margins have moderated from 13.84% in 2023 to 8.56% in 2025. The company maintains strong profitability with a 69.87% gross margin and recently announced a $0.24 quarterly dividend.
ZBH presents a mixed outlook with positive earnings momentum and analyst consensus price target of $103.11 offering 12% upside potential. However, rising debt levels and competitive pressures in medical technology pose risks. Institutional ownership trends show continued interest, with State Street increasing its position by 0.6% in Q3 2026. The stock's valuation at 22.35 P/E appears reasonable given the company's market leadership position.
Trailing returns across standard periods
Latest headlines on both assets
Constellation Brands, Inc. is a US producer and marketer of beer, wine, and spirits, known for importing Mexican beer brands Corona and Modelo alongside a portfolio of wine and craft spirits labels.
Read more on STZ →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →